Pharma & Life Sciences: Clinical Trial Analytics on Microsoft Fabric¶

Executive Summary¶

A top-20 global pharmaceutical company managing 45 active clinical trials across 8 therapeutic areas with 12,000 enrolled subjects deploys Microsoft Fabric as its unified analytics platform for clinical data integration, safety signal detection, and regulatory reporting. The platform consolidates data from six operational systems (EDC, CTMS, IRT, ePRO, lab, and safety databases) into a single governed lakehouse, enabling near-real-time enrollment dashboards and automated safety signal surveillance while maintaining full 21 CFR Part 11 and GxP compliance.

Estimated cost: ~$30,000/month (Fabric F64 + Purview + supporting services) Primary ROI drivers: Accelerated enrollment timelines (~18% improvement), faster safety signal detection (from 14 days to <48 hours), and reduced manual reconciliation effort (~2,400 analyst-hours/year saved).

Company Profile¶

Architecture¶

System Landscape¶

                    ┌─────────────────────────────────────────────┐
                    │           SOURCE SYSTEMS                     │
                    │                                              │
                    │  ┌────────┐ ┌────────┐ ┌────────┐          │
                    │  │  EDC   │ │  CTMS  │ │  IRT   │          │
                    │  │(Medidata│ │(Oracle │ │(IXRS)  │          │
                    │  │ Rave)  │ │ Siebel)│ │        │          │
                    │  └───┬────┘ └───┬────┘ └───┬────┘          │
                    │      │          │          │                 │
                    │  ┌───┴────┐ ┌───┴────┐ ┌───┴────┐          │
                    │  │  ePRO  │ │  Lab   │ │ Safety │          │
                    │  │(Signant│ │(Quest/ │ │(Argus  │          │
                    │  │ Health)│ │ LabCorp│ │ Safety)│          │
                    │  └───┬────┘ └───┬────┘ └───┬────┘          │
                    └──────┼──────────┼──────────┼────────────────┘
                           │          │          │
                    ┌──────▼──────────▼──────────▼────────────────┐
                    │         MICROSOFT FABRIC F64                 │
                    │                                              │
                    │  ┌──────────────────────────────────────┐   │
                    │  │     BRONZE: bronze_pharma_trials      │   │
                    │  │  Raw EDC, CTMS, IRT, ePRO, Lab, AE   │   │
                    │  │  Append-only, audit-trail preserved   │   │
                    │  └──────────────┬───────────────────────┘   │
                    │                 │                             │
                    │  ┌──────────────▼───────────────────────┐   │
                    │  │     SILVER: silver_pharma_study       │   │
                    │  │  SDTM-aligned domains (DM, AE, VS)   │   │
                    │  │  MedDRA coded, visit-window checked   │   │
                    │  │  Protocol deviations flagged          │   │
                    │  └──────┬────────────────┬──────────────┘   │
                    │         │                │                    │
                    │  ┌──────▼──────┐  ┌──────▼──────────────┐   │
                    │  │    GOLD:    │  │       GOLD:          │   │
                    │  │gold_pharma_ │  │  gold_pharma_        │   │
                    │  │enrollment   │  │  safety              │   │
                    │  │             │  │                       │   │
                    │  │• Enrollment │  │• Disproportionality  │   │
                    │  │  curves     │  │  analysis (PRR/ROR)  │   │
                    │  │• Site rank  │  │• SAE timeline KPIs   │   │
                    │  │• Screen     │  │• CIOMS compliance    │   │
                    │  │  failure %  │  │• MedDRA SOC treemap  │   │
                    │  └─────────────┘  └──────────────────────┘   │
                    │                                              │
                    │  ┌──────────────────────────────────────┐   │
                    │  │     POWER BI (Direct Lake)            │   │
                    │  │  Trial Command Center Dashboard       │   │
                    │  └──────────────────────────────────────┘   │
                    └──────────────────────────────────────────────┘

Data Flow¶

flowchart LR
    EDC[EDC - Medidata Rave] -->|SFTP/API| Bronze
    CTMS[CTMS - Oracle Siebel] -->|ODBC| Bronze
    IRT[IRT/IXRS] -->|API| Bronze
    ePRO[ePRO - Signant] -->|API| Bronze
    Lab[Central Lab] -->|HL7/SFTP| Bronze
    Safety[Argus Safety] -->|E2B XML| Bronze

    Bronze[bronze_pharma_trials] --> Silver[silver_pharma_study]
    Silver --> GoldEnroll[gold_pharma_enrollment]
    Silver --> GoldSafety[gold_pharma_safety]
    GoldEnroll --> PBI[Power BI]
    GoldSafety --> PBI
    GoldSafety --> Argus[Argus Safety Writeback]

Clinical Trial Data Integration¶

Source Systems and Data Volumes¶

Bronze Layer: Raw Ingestion¶

All source data lands in bronze_pharma_trials with: - Original payloads preserved (XML, CSV, JSON, HL7) - Append-only Delta Lake tables - Source system metadata (_source_system, _extract_timestamp) - Immutable audit trail for 21 CFR Part 11 compliance - No transformations - raw fidelity maintained

Silver Layer: SDTM-Aligned Transformations¶

The silver layer (silver_pharma_study) applies CDISC SDTM-like domain mappings:

Additional silver transformations: - Visit window compliance: Flag visits outside protocol-defined windows (+-3 days) - Protocol deviation detection: Automated flagging of inclusion/exclusion violations - Data quality scoring: Completeness, consistency, and conformance metrics per CRF page - MedDRA coding validation: Verify PT-to-SOC hierarchy consistency

Gold Layer: Analytics and KPIs¶

Enrollment KPIs (gold_pharma_enrollment)¶

Safety Signal KPIs (gold_pharma_safety)¶

Patient Recruitment Optimization¶

Site Performance Analytics¶

The platform ranks all 320 clinical sites across a composite score:

Site Score = 0.30 × Enrollment_Rate
           + 0.25 × Data_Quality_Score
           + 0.20 × Query_Resolution_Time
           + 0.15 × Protocol_Compliance
           + 0.10 × Retention_Rate

Actionable outputs: - Bottom-quartile site identification for targeted monitoring visits - Predictive enrollment completion dates per study using Bayesian forecasting - Country-level enrollment heat maps for regulatory submission planning - Site-to-site patient demographic comparison for population representativeness

Enrollment Velocity Tracking¶

Real-time enrollment curves compare actual vs. planned recruitment: - Green zone: Within 10% of planned trajectory - Yellow zone: 10-25% behind plan, triggers recruitment boost actions - Red zone: >25% behind plan, triggers protocol amendment consideration

Safety Signal Detection¶

MedDRA Coding and Hierarchy¶

All adverse events are coded using MedDRA (Medical Dictionary for Regulatory Activities) version 26.1:

Level               Example
─────               ───────
SOC (System Organ)  Gastrointestinal disorders
HLGT                Gastrointestinal signs and symptoms
HLT                 Nausea and vomiting symptoms
PT (Preferred Term) Nausea
LLT (Lowest Level)  Nausea, intermittent

Disproportionality Analysis¶

The gold safety layer computes signal detection metrics:

• PRR (Proportional Reporting Ratio): Compares the proportion of a specific AE for the study drug vs. comparator/background rate
• ROR (Reporting Odds Ratio): Odds ratio with 95% confidence interval
• EBGM (Empirical Bayesian Geometric Mean): Multi-item gamma-Poisson shrinker for rare events

Signals exceeding thresholds trigger automated alerts to the Drug Safety team and are queued for pharmacovigilance review.

CIOMS Reporting Timelines¶

Real-World Evidence (RWE)¶

Label Expansion Use Case¶

Fabric ingests de-identified claims and EHR data to support post-approval studies:

RWE analytics support: - Comparative effectiveness vs. standard of care - Safety surveillance in broader populations - Health economic outcomes (HEOR) for payer submissions - Pediatric extrapolation studies

Drug Supply Chain¶

Serialization and Track & Trace¶

Fabric tracks drug supply from manufacturer to clinical site:

Temperature Excursion Monitoring¶

IoT sensors on clinical supply shipments stream temperature data through Fabric Eventstreams. KQL queries in Eventhouse detect excursions:

ColdChainTelemetry
| where Temperature > MaxThreshold or Temperature < MinThreshold
| summarize ExcursionDuration = sum(IntervalMinutes) by ShipmentId, BatchLot
| where ExcursionDuration > AllowedExcursionMinutes
| project ShipmentId, BatchLot, ExcursionDuration, Alert = "QUARANTINE"

21 CFR Part 11 Compliance¶

Electronic Signatures¶

All data modifications in Fabric are governed by Part 11 requirements:

Audit Trails¶

• Delta Lake time travel: Every transaction is versioned; DESCRIBE HISTORY provides full audit trail
• Purview lineage: End-to-end data lineage from source system to gold KPI
• Immutable bronze: Append-only ingestion preserves original records
• SQL audit logs: All workspace queries logged and retained for inspection period

Validated Systems¶

Part 11 Compliant Storage¶

• Delta Lake provides ACID transactions and immutable versioning
• OneLake encryption at rest (AES-256) and in transit (TLS 1.2+)
• Customer-managed keys (CMK) for sensitive clinical data
• Data retention policies aligned with ICH E6 (25 years post-study)
• Geographic data residency controls per regulatory jurisdiction

GxP Computerized System Validation¶

ALCOA+ Principles¶

CSV (Computerized System Validation) Approach¶

┌─────────────────────────────────────────────┐
│         GAMP 5 Category 5                   │
│         (Custom Application)                │
│                                             │
│  ┌─────────┐  ┌─────────┐  ┌─────────┐    │
│  │   URS   │  │   FS    │  │   DS    │    │
│  │  User   │→ │Functional│→ │ Design  │    │
│  │  Req    │  │  Spec   │  │  Spec   │    │
│  └────┬────┘  └────┬────┘  └────┬────┘    │
│       │            │            │           │
│       ▼            ▼            ▼           │
│  ┌─────────┐  ┌─────────┐  ┌─────────┐    │
│  │   PQ    │  │   OQ    │  │   IQ    │    │
│  │Performnc│← │Operatnl │← │Install  │    │
│  │  Qual   │  │  Qual   │  │  Qual   │    │
│  └─────────┘  └─────────┘  └─────────┘    │
│                                             │
│  Traceability Matrix links URS → Tests     │
└─────────────────────────────────────────────┘

Cost Analysis¶

Monthly Cost Breakdown¶

ROI Calculation¶

Implementation Timeline¶

Key Risks and Mitigations¶

Power BI Dashboard: Trial Command Center¶

Page 1: Enrollment Overview¶

• Enrollment curve (actual vs. planned) with confidence bands
• Screen failure funnel by study and site
• Geographic enrollment heat map
• Site activation timeline (Gantt)

Page 2: Safety Surveillance¶

• AE incidence by MedDRA SOC (treemap)
• Signal detection scorecard (PRR, ROR)
• SAE reporting compliance gauge (% within CIOMS timelines)
• Drug-related AE trend (line chart by study month)

Page 3: Site Performance¶

• Composite site score ranking (bar chart)
• Query resolution time distribution
• Data quality completeness matrix
• Protocol deviation rate by site tier

Page 4: Drug Supply¶

• Cold chain temperature timeline
• Kit inventory by site (stock-out risk)
• Shipment status tracker
• Batch expiry calendar

References¶

1. FDA 21 CFR Part 11 - Electronic Records; Electronic Signatures
2. ICH E6(R2) - Good Clinical Practice
3. GAMP 5 - A Risk-Based Approach to Compliant GxP Computerized Systems
4. ICH E2B(R3) - Electronic Transmission of Individual Case Safety Reports
5. CDISC SDTM Implementation Guide v3.4
6. MedDRA Version 26.1 Introductory Guide
7. FDA Drug Supply Chain Security Act (DSCSA)
8. Microsoft Fabric Documentation - OneLake Security and Compliance
9. ISPE GAMP Good Practice Guide: Data Integrity
10. ICH E8(R1) - General Considerations for Clinical Studies

Last Updated: 2026-04-27 Industry Vertical: Pharma & Life Sciences Compliance Frameworks: 21 CFR Part 11, GxP, ICH GCP, GDPR, DSCSA